Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
|Podcasts|November 4, 2020
S2E6: Vaginal dilators with Dr. Michael Krychman
Author(s)Lindsey Carr, Editor
Dr. Krychman is a gynecologist who specializes in sexual health and survivorship medicine. He is executive director of the Southern California Center for Sexual Health and Survivorship Medicine Inc. in Newport Beach, Calif.
Advertisement
In this episode of Pap Talk, Senior Editor Angie DeRosa interviewed Dr. Michael Krychman to discuss vaginal dilators in preparation for his feature article in the
Stay tuned for the full, peer-reviewed article and watch the video
Advertisement
Related to this article
Pritelivir healed all HSV lesions by day 28 in 63% of immunocompromised adults vs 34% with comparators.
Fezolinetant (Veozah) was linked to objective and patient-reported sleep gains in OPTION-VMS, with no new safety signals observed.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
The prospective SOARA study will measure how often a 98%-specific ovarian cancer screening blood test leads to invasive procedures.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
HPV vaccine before pregnancy tied to fewer adverse pregnancy outcomes
3
Perimenopause and mental health: Beyond hormonal vs psychological
4
Real-world data link fezolinetant to fewer nighttime awakenings
5